4//SEC Filing
Evolent Health, Inc. 4
Accession 0001654824-17-000001
$EVHCIK 0001628908operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:35 PM ET
Size
15.8 KB
Accession
0001654824-17-000001
Insider Transaction Report
Form 4
Stone Lydia
Principal Accounting Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2017-06-01$6.87/sh+1,000$6,870→ 10,587 total - Sale
Class A Common Stock
2017-06-01$22.87/sh−2,908$66,506→ 9,587 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-06-01−2,908→ 8,722 totalExercise: $10.27Exp: 2026-03-01→ Class A Common Stock (2,908 underlying) - Sale
Class A Common Stock
2017-06-01$22.95/sh−887$20,357→ 9,587 total - Sale
Class A Common Stock
2017-06-01$23.04/sh−1,000$23,040→ 9,587 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-06-01−1,000→ 2,000 totalExercise: $6.87Exp: 2025-01-01→ Class A Common Stock (1,000 underlying) - Exercise/Conversion
Class A Common Stock
2017-06-01$10.27/sh+2,908$29,865→ 12,495 total
Footnotes (4)
- [F1]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F2]The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $22.75-23.00, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote.
- [F3]The Class A Common Stock Options exercised vested on January 1, 2017.
- [F4]The Class A Common Stock Options exercised vested on March 1, 2017.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001628908
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:35 PM ET
- Size
- 15.8 KB